中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2014年
8期
73-74,77
,共3页
老年性胃溃疡%埃索美拉唑%安全性
老年性胃潰瘍%埃索美拉唑%安全性
노년성위궤양%애색미랍서%안전성
Elderly patients with gastric ulcer%Esomeprazole%Safety
目的:对埃索美拉唑在老年性胃溃疡患者治疗中的安全性进行分析。方法在我院2012~2013年两年接收治疗的老年性胃溃疡患者中选取68例,分成两组,对照组患者采用奥美拉唑进行治疗,观察组患者采用埃索美拉唑进行治疗。对比分析其临床疗效。结果观察组患者的临床治疗总有效率为94.1%,对照组为73.5%,差异有统计学意义(P<0.05);观察组和对照组患者的Hp根除率分别为88.2%和67.6%,差异有统计学意义(P<0.05);观察组和对照组患者的不良反应发生率分别为8.8%和14.7%,差异有统计学意义(P<0.05)。结论采用埃索美拉唑治疗老年性胃溃疡,有助于提高临床治疗有效率,降低不良反应的发生,具有较高安全性,值得推广。
目的:對埃索美拉唑在老年性胃潰瘍患者治療中的安全性進行分析。方法在我院2012~2013年兩年接收治療的老年性胃潰瘍患者中選取68例,分成兩組,對照組患者採用奧美拉唑進行治療,觀察組患者採用埃索美拉唑進行治療。對比分析其臨床療效。結果觀察組患者的臨床治療總有效率為94.1%,對照組為73.5%,差異有統計學意義(P<0.05);觀察組和對照組患者的Hp根除率分彆為88.2%和67.6%,差異有統計學意義(P<0.05);觀察組和對照組患者的不良反應髮生率分彆為8.8%和14.7%,差異有統計學意義(P<0.05)。結論採用埃索美拉唑治療老年性胃潰瘍,有助于提高臨床治療有效率,降低不良反應的髮生,具有較高安全性,值得推廣。
목적:대애색미랍서재노년성위궤양환자치료중적안전성진행분석。방법재아원2012~2013년량년접수치료적노년성위궤양환자중선취68례,분성량조,대조조환자채용오미랍서진행치료,관찰조환자채용애색미랍서진행치료。대비분석기림상료효。결과관찰조환자적림상치료총유효솔위94.1%,대조조위73.5%,차이유통계학의의(P<0.05);관찰조화대조조환자적Hp근제솔분별위88.2%화67.6%,차이유통계학의의(P<0.05);관찰조화대조조환자적불량반응발생솔분별위8.8%화14.7%,차이유통계학의의(P<0.05)。결론채용애색미랍서치료노년성위궤양,유조우제고림상치료유효솔,강저불량반응적발생,구유교고안전성,치득추엄。
Objective To analyze the safety of esomeprazole in the treatment of elderly patients with gastric ulcer. Methods Sixty-eight elderly patients with gastric ulcer treated in our hospital from 2012 to 2013 were divided into two groups. The control group received omeprazole treatment and the observation group received esomeprazole treatment. The clinical efficacy of the two groups was analyzed comparatively. Results The clinical total effective treatment rate of the observation group was 94.1% and that of the control group was only 73.5%, with significant difference (P<0.05);The Hp elimination rates of the observation group and the control group were 88.2%and 67.6%respectively, with significant difference (P<0.05); The incidences of adverse reactions of the observation group and the control group were 8.8%and 14.7%respectively, with significant difference (P<0.05). Conclusion The application of esomeprazole in the treatment of elderly patients with gastric ulcer is conducive to improving the clinical effective treatment rate and reducing the occurrence of adverse reactions and has high safety, thereby worthy of promotion.